You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Albumin-Bound Paclitaxel

Showing 51 - 75 of 4,750
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in

Completed
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +6 more
  • Houston, Texas
  • +4 more
Aug 31, 2022

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),

Not yet recruiting
  • Locally Advanced Unresectable Esophageal Squamous Carcinoma
  • Docetaxel for Injection (Albumin-bound)
  • +4 more
  • Jinan, Shandong, China
  • +1 more
Nov 16, 2023

Solid Tumors Trial in United States (CORT125134 with nab-paclitaxel)

Completed
Has Results
  • Solid Tumors
  • Relacorilant with nab-paclitaxel
  • Scottsdale, Arizona
  • +3 more
Nov 9, 2022

Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in China (Tislelizumab, Albumin-Bound Paclitaxel,

Recruiting
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Squamous Cell Carcinoma
  • Beijing, Beijing, China
  • +13 more
Aug 22, 2023

Advanced Solid Tumor Trial (CVL218)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 9, 2023

Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7, Stage IA Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Resectable Pancreatic Carcinoma
  • +6 more
  • Gemcitabine Hydrochloride
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 16, 2022

Advanced Triple Negative Breast Cancer Trial in Fuzhou (Apatinib Mesylate, Albumin-Bound Paclitaxel)

Not yet recruiting
  • Advanced Triple Negative Breast Cancer
  • Apatinib Mesylate
  • Albumin-Bound Paclitaxel
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Aug 18, 2021

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Cervical Cancer, Neoadjuvant Chemo, Bulky Tumor Trial in Guangzhou (Albumin-Bound Paclitaxel, Carboplatin)

Recruiting
  • Cervical Cancer
  • +2 more
  • Guangzhou, Guangdone, China
    Sun Yat-sen University Cancer Center
May 9, 2022

Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic

Not yet recruiting
  • Resectable Intrahepatic Cholangiocarcinoma
  • +4 more
  • Atlanta, Georgia
  • +2 more
Aug 19, 2022

HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)

Not yet recruiting
  • HER2 Positive Advanced Solid Tumors
  • HypoSti.CAR-HER2 T cells
  • +2 more
  • (no location specified)
Jan 12, 2023

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Nashville (procedure, drug, other, biological, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 11, 2022

Solid Tumors Trial (TCR-T cells, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumors
  • TCR-T cells
  • +4 more
  • (no location specified)
Dec 12, 2022

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma Trial in Duarte

Recruiting
  • Stage III Pancreatic Cancer AJCC v8
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 9, 2021

Esophageal Squamous Cell Carcinoma Trial (Envafolimab, Albumin-Bound Paclitaxel, Carboplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Sep 21, 2022

Penile Cancer Trial in Guangzhou (Albumin-Bound Paclitaxel, Ifosfamide, Cisplatin)

Completed
  • Penile Cancer
  • Albumin-Bound Paclitaxel
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 8, 2022

Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 23, 2022

Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus

Not yet recruiting
  • Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
  • NAB-Paclitaxel plus Cisplatin
  • Cisplatin plus Epirubicin plus Cyclophosphamide
  • Shanghai, Shanghai, China
    Yian Zhang
Apr 17, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Gastric Adenocarcinoma Trial in Beijing (Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1)

Recruiting
  • Gastric Adenocarcinoma
  • Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 27, 2022

Breast Cancer Trial in China (Albumin-bound paclitaxel combined with carboplatin, Epirubicin combined with docetaxel)

Recruiting
  • Breast Cancer
  • Albumin-bound paclitaxel combined with carboplatin
  • Epirubicin combined with docetaxel
  • Harbin, Heilongjiang, China
  • +6 more
Jul 18, 2021

Pancreatic Cancer Trial in Tianjin (SHR-1020+albumin-bound paclitaxel)

Recruiting
  • Pancreatic Cancer
  • SHR-1020+albumin-bound paclitaxel
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
May 21, 2021